Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06749444

Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Jimmi Nielsen · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

Using a randomized controlled design, the project aims to test if cognitive behavioral therapy interventions specifically targeting sleep disorders can significantly lessen the burden of the disrupted sleep in patients with treatment resistant schizophrenia (TRS) and by proxy lead to a reduction in psychotic symptoms and improvement in quality of life. We are including treatment-resistant patients with schizophrenia other nonorganic and chronic psychoses and in addition meeting the criteria of a sleep or circadian disorder. Included patients will be block randomized to either 8-10 sessions of CBT-I (active treatment) with a specific focus on sleep or 8-10 sessions of regularCBT with a specific focus on patients' psychopathology (treatment as usual) approx.1 session/week. After 12 weeks the full battery of assessments will be repeated forboth groups. Primary analyses will be to identify group-difference in changes using repeated measure ANOVA.

Conditions

Interventions

TypeNameDescription
OTHERCBT-ICognitive therapy tailored for insomnia symptoms.
OTHERCBTCognitive behavioral therapy for general psychopathology

Timeline

Start date
2024-11-28
Primary completion
2026-06-30
Completion
2027-04-30
First posted
2024-12-27
Last updated
2026-01-20

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06749444. Inclusion in this directory is not an endorsement.